Vigilant Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21
Closed -$4K 476
2022
Q4
$4K Hold
21
﹤0.01% 458
2022
Q3
$4K Hold
21
﹤0.01% 526
2022
Q2
$4K Hold
21
﹤0.01% 541
2022
Q1
$5K Sell
21
-186
-90% -$43.7K ﹤0.01% 526
2021
Q4
$56K Sell
207
-18
-8% -$4.46K ﹤0.01% 303
2021
Q3
$54K Buy
225
+39
+21% +$9.83K ﹤0.01% 261
2021
Q2
$44K Sell
186
-67
-26% -$15.3K ﹤0.01% 283
2021
Q1
$55K Hold
253
﹤0.01% 233
2020
Q4
$44K Sell
253
-157
-38% -$27.1K ﹤0.01% 237
2020
Q3
$66K Buy
+410
New +$65K 0.01% 203
2018
Q2
Sell
-63
Closed -$9K 491
2018
Q1
$9K Buy
+63
New +$9.25K ﹤0.01% 377

Other funds holding LH

Vigilant Capital Management's LH Position: Q1 2023 in Review

Vigilant Capital Management sold out of Labcorp (LH) in Q1 2023, closing a stake of 21 shares — an estimated $4K sold.

Vigilant Capital Management first reported a position in LH in Q1 2018 and held it in 11 quarters. The position peaked at $66K in Q3 2020. 941 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • Vigilant Capital Management reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • Vigilant Capital Management sold 21 Labcorp shares in Q1 2023, an estimated $4K.
  • Vigilant Capital Management first reported a position in Labcorp in Q1 2018 and held it in 11 quarters.
  • Vigilant Capital Management's Labcorp position peaked at $66K in Q3 2020.
  • 941 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Vigilant Capital Management's 13F filing for Q1 2023, filed 1 May 2023.